Joanne Balfe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joanne Balfe has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Eleanor J. Molloy
Discipline of Paediatrics, Trinity College Dublin, The University of Dublin, Dublin, Ireland
2 shared publications A. Stokes
Independent Researcher (Medical Statistics Support) London UK
1 shared publication- Ana Moreno-Olivera
Department of Immunology, Trinity Translational Medicine Institute, Dublin 8, Ireland
1 shared publication - Ashanty M. Melo
Paediatrics, Trinity College Dublin, Children's Health Ireland (CHI) at Tallaght, Dublin, Ireland
1 shared publication C O’Neill
Discipline of Paediatrics, Trinity College Dublin
1 shared publicationC Quinn
1 shared publication
Latest Publications
- Open Access
- 17 June 2026
- Published by Wiley in Acta Paediatrica
- Vol. 115 (9) , 1883-1890
Serum Creatinine Levels in Children With Down Syndrome: A Single‐Centre Retrospective Study in Ireland
Aim: To assess the proportion of children with Down syndrome (DS) with creatinine levels above standard paediatric reference ranges in a single‐centre Irish outpatient cohort. Methods: We performed a retrospective cross‐sectional study of children aged 0–16 years attending the DS Clinic at Children's Health Ireland, Tallaght, between June 2022 and June 2024. Children with known renal disease and acute results were excluded. Creatinine levels were analysed using age‐ and sex‐specific reference ranges. The proportion with creatinine above the upper reference limit was compared with the expected proportion of 2.5% using a one‐sided exact binomial test. Estimated glomerular filtration rate (eGFR) was calculated using the bedside Schwartz equation, where height was available. Results: A total of 194 patients were included. Among them, 52 (26.8%) had creatinine levels above the upper reference limit ( p < 0.0001). Additionally, 42 (21.6%) had persistently elevated creatinine ( p < 0.0001). Height was available for 124 children. Of those, 42 (34%) had an eGFR < 90 mL/min/1.73 m 2 and 1 (0.8%) had an eGFR < 60 mL/min/1.73 m 2 . Conclusion: Children with DS in this Irish clinic frequently had creatinine levels above standard reference ranges. Further studies are required to clarify the clinical significance of these findings.
- 17 June 2026
- Published by Wiley in Acta Paediatrica
- Vol. 115 (9) , 1883-1890
Open AccessSerum Creatinine Levels in Children With Down Syndrome: A Single‐Centre Retrospective Study in Ireland
Aim: To assess the proportion of children with Down syndrome (DS) with creatinine levels above standard paediatric reference ranges in a single‐centre Irish outpatient cohort. Methods: We performed a retrospective cross‐sectional study of children aged 0–16 years attending the DS Clinic at Children's Health Ireland, Tallaght, between June 2022 and June 2024. Children with known renal disease and acute results were excluded. Creatinine levels were analysed using age‐ and sex‐specific reference ranges. The proportion with creatinine above the upper reference limit was compared with the expected proportion of 2.5% using a one‐sided exact binomial test. Estimated glomerular filtration rate (eGFR) was calculated using the bedside Schwartz equation, where height was available. Results: A total of 194 patients were included. Among them, 52 (26.8%) had creatinine levels above the upper reference limit ( p < 0.0001). Additionally, 42 (21.6%) had persistently elevated creatinine ( p < 0.0001). Height was available for 124 children. Of those, 42 (34%) had an eGFR < 90 mL/min/1.73 m 2 and 1 (0.8%) had an eGFR < 60 mL/min/1.73 m 2 . Conclusion: Children with DS in this Irish clinic frequently had creatinine levels above standard reference ranges. Further studies are required to clarify the clinical significance of these findings.
- Open Access
- 4 June 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 60
Hospital activity amongst children aged 0–19 with and without life-limiting conditions in Ireland, 2009–2024
Background Life-limiting conditions (LLCs) in children include conditions where curative treatment may be feasible but can fail or where there is no reasonable hope of cure. Children and young people with LLCs have been found to be resource-intense healthcare users, but evidence is limited to a small number of countries. Responding to this gap, this paper provides detailed information on inpatient hospital activity for children aged 0–19 with and without LLCs in Ireland to inform healthcare policy and provision, including paediatric palliative care. Methods Data: public acute hospital discharges aged 0–19, national Hospital In-Patient Enquiry. Discharges categorised as: with and without LLCs (recorded in any of 30 diagnostic fields). Descriptive analysis: number of discharges over time; inpatients only: principal diagnoses and procedures, resource use (length of stay, intensive care, complexity), deaths. Results Day and inpatient public acute hospital LLC discharges increased from 13.1% to 14.3% of total discharges aged 0–19 between 2009–2019. All discharges in this age group fell by 24.5% in 2020 (Covid-19 onset), increasing since then. Inpatient LLC discharges aged 0–19 accounted for <8% of total inpatient discharges aged 0–19 in Irish public acute hospitals in 2019 (pre-Covid-19), used almost 20% of total bed days, 23.3% of intensive care bed days. Conclusions Inpatient LLC discharges in Irish public acute hospitals were complex and resource-use intensive. The findings highlighted important lessons for healthcare policy and provision, palliative care training and education, hospital management, data collection and further analysis in this field.
- 4 June 2026
- Published by F1000 Research Ltd in HRB Open Research
- Vol. 9, 60
Open AccessHospital activity amongst children aged 0–19 with and without life-limiting conditions in Ireland, 2009–2024
Background Life-limiting conditions (LLCs) in children include conditions where curative treatment may be feasible but can fail or where there is no reasonable hope of cure. Children and young people with LLCs have been found to be resource-intense healthcare users, but evidence is limited to a small number of countries. Responding to this gap, this paper provides detailed information on inpatient hospital activity for children aged 0–19 with and without LLCs in Ireland to inform healthcare policy and provision, including paediatric palliative care. Methods Data: public acute hospital discharges aged 0–19, national Hospital In-Patient Enquiry. Discharges categorised as: with and without LLCs (recorded in any of 30 diagnostic fields). Descriptive analysis: number of discharges over time; inpatients only: principal diagnoses and procedures, resource use (length of stay, intensive care, complexity), deaths. Results Day and inpatient public acute hospital LLC discharges increased from 13.1% to 14.3% of total discharges aged 0–19 between 2009–2019. All discharges in this age group fell by 24.5% in 2020 (Covid-19 onset), increasing since then. Inpatient LLC discharges aged 0–19 accounted for <8% of total inpatient discharges aged 0–19 in Irish public acute hospitals in 2019 (pre-Covid-19), used almost 20% of total bed days, 23.3% of intensive care bed days. Conclusions Inpatient LLC discharges in Irish public acute hospitals were complex and resource-use intensive. The findings highlighted important lessons for healthcare policy and provision, palliative care training and education, hospital management, data collection and further analysis in this field.
- 15 May 2019
- Published by Morressier GmbH
Implementation of a “Sterile Cockpit” to Improve Medication Safety in a Children's Hospice
Welcome to the largest platform for early-stage research
- 15 May 2019
- Published by Morressier GmbH
Implementation of a “Sterile Cockpit” to Improve Medication Safety in a Children's Hospice
Welcome to the largest platform for early-stage research
- 15 May 2019
- Published by Morressier GmbH
An Assessment of the Learning Needs in Paediatric Palliative Care
Welcome to the largest platform for early-stage research
- 15 May 2019
- Published by Morressier GmbH
An Assessment of the Learning Needs in Paediatric Palliative Care
Welcome to the largest platform for early-stage research
- 15 January 2019
- Vol. 112 (1) , 862
Permanent Childhood Hearing Loss in Ireland: Diagnostic Yield from Aetiological Evaluation in a Paediatric Clinic
- 15 January 2019
- Vol. 112 (1) , 862
Permanent Childhood Hearing Loss in Ireland: Diagnostic Yield from Aetiological Evaluation in a Paediatric Clinic
- Open Access
- 3 November 2018
- Published by Springer Nature in BMC Immunology
- Vol. 19 (1) , 31
Altered endotoxin responsiveness in healthy children with Down syndrome
Down syndrome (DS) is the most common syndromic immunodeficiency with an increased risk of infection, mortality from sepsis, and autoinflammation. Innate immune function is altered in DS and therefore we examined responses in CD11b and Toll like receptor 4 (TLR-4), which are important immune cell surface markers upregulated in response to Lipopolysaccharide (LPS) endotoxin, and the immunomodulator melatonin. Neutrophil and monocyte responses to LPS and melatonin in children with Down syndrome (DS) who were clinically stable were compared to age-matched controls. Whole blood was incubated with LPS and melatonin and the relative expression of CD11b and TLR-4 evaluated by flow cytometry. Children with DS had an increased response to LPS in neutrophils and intermediate monocytes, while also having elevated TLR-4 expression on non-classical monocytes compared to controls at baseline. Melatonin reduced CD11b expression on neutrophils, total monocytes, both classical and intermediate sub-types, in children with DS and controls. Melatonin could represent a useful clinical adjunct in the treatment of sepsis as an immunomodulator. Children with DS had increased LPS responses which may contribute to the more adverse outcomes seen in sepsis.
- 3 November 2018
- Published by Springer Nature in BMC Immunology
- Vol. 19 (1) , 31
Open AccessAltered endotoxin responsiveness in healthy children with Down syndrome
Down syndrome (DS) is the most common syndromic immunodeficiency with an increased risk of infection, mortality from sepsis, and autoinflammation. Innate immune function is altered in DS and therefore we examined responses in CD11b and Toll like receptor 4 (TLR-4), which are important immune cell surface markers upregulated in response to Lipopolysaccharide (LPS) endotoxin, and the immunomodulator melatonin. Neutrophil and monocyte responses to LPS and melatonin in children with Down syndrome (DS) who were clinically stable were compared to age-matched controls. Whole blood was incubated with LPS and melatonin and the relative expression of CD11b and TLR-4 evaluated by flow cytometry. Children with DS had an increased response to LPS in neutrophils and intermediate monocytes, while also having elevated TLR-4 expression on non-classical monocytes compared to controls at baseline. Melatonin reduced CD11b expression on neutrophils, total monocytes, both classical and intermediate sub-types, in children with DS and controls. Melatonin could represent a useful clinical adjunct in the treatment of sepsis as an immunomodulator. Children with DS had increased LPS responses which may contribute to the more adverse outcomes seen in sepsis.
- 10 September 2018
- Vol. 111 (8) , 804
National Survey Of The Aetiological Assessment Service Of Permanent Childhood Hearing Loss In Ireland
Aim The Universal Neonatal Hearing Screening Programme (UNHS) was implemented nationally in 2014. All infants identified with permanent childhood hearing loss (PCHL) should have a paediatric assessment performed. This survey aimed to assess available paediatric services and to inform service development. Methods All paediatricians involved in assessment of infants with PCHL were identified. A questionnaire was developed using the BAAP standards. Results were collated on excel. Results Thirty-three paediatricians assess children with PCHL, only 18% (6/33) had received specific training. Waiting time for assessment was beyond the recommended timeframe in the majority of cases (mean 14.4 weeks, range 2-52). Timely access to services such as MRI, genetics and ophthalmology was limited. Conclusion The survey highlights significant deficits in the paediatric component of the UNHS. A model of regionalisation with recommendations to improve the paediatric skill set, resources and supporting services is suggested.
- 10 September 2018
- Vol. 111 (8) , 804
National Survey Of The Aetiological Assessment Service Of Permanent Childhood Hearing Loss In Ireland
Aim The Universal Neonatal Hearing Screening Programme (UNHS) was implemented nationally in 2014. All infants identified with permanent childhood hearing loss (PCHL) should have a paediatric assessment performed. This survey aimed to assess available paediatric services and to inform service development. Methods All paediatricians involved in assessment of infants with PCHL were identified. A questionnaire was developed using the BAAP standards. Results were collated on excel. Results Thirty-three paediatricians assess children with PCHL, only 18% (6/33) had received specific training. Waiting time for assessment was beyond the recommended timeframe in the majority of cases (mean 14.4 weeks, range 2-52). Timely access to services such as MRI, genetics and ophthalmology was limited. Conclusion The survey highlights significant deficits in the paediatric component of the UNHS. A model of regionalisation with recommendations to improve the paediatric skill set, resources and supporting services is suggested.
- 14 July 2018
- Published by BMJ in Archives of Disease in Childhood
- Vol. 103 (9) , 910-911
Question 2: Does heavy metal chelation therapy improve the symptoms of autism spectrum disorder
In children with ASD (patient) does pharmacological chelation therapy (intervention) improve behaviour (outcome)?
- 14 July 2018
- Published by BMJ in Archives of Disease in Childhood
- Vol. 103 (9) , 910-911
Question 2: Does heavy metal chelation therapy improve the symptoms of autism spectrum disorder
In children with ASD (patient) does pharmacological chelation therapy (intervention) improve behaviour (outcome)?
- 5 June 2018
- Published by BMJ in Archives of Disease in Childhood
- Vol. 104 (2) , 200-201
Coeliac disease in children with Down syndrome in Ireland
Down syndrome (DS) is one of the most common chromosomal abnormalities with an incidence of 1:444 births.1 Ireland has the highest prevalence of DS in Europe, which may be partially explained by the legislation against termination of pregnancy.1 Individuals with DS are at higher risk of developing coeliac disease (CD) compared with the general population (5%–10% vs 1%).2 CD can be difficult to diagnose due to the frequency of asymptomatic cases, and it can be particularly difficult to identify clinically in children with DS in whom short stature, abdominal distension and constipation are common clinical features. The European Society …
- 5 June 2018
- Published by BMJ in Archives of Disease in Childhood
- Vol. 104 (2) , 200-201
Coeliac disease in children with Down syndrome in Ireland
Down syndrome (DS) is one of the most common chromosomal abnormalities with an incidence of 1:444 births.1 Ireland has the highest prevalence of DS in Europe, which may be partially explained by the legislation against termination of pregnancy.1 Individuals with DS are at higher risk of developing coeliac disease (CD) compared with the general population (5%–10% vs 1%).2 CD can be difficult to diagnose due to the frequency of asymptomatic cases, and it can be particularly difficult to identify clinically in children with DS in whom short stature, abdominal distension and constipation are common clinical features. The European Society …
- 1 March 2015
- Vol. 108 (3) , 93
Children with life-limiting conditions: establishing accurate prevalence figures.
- 1 March 2015
- Vol. 108 (3) , 93
Children with life-limiting conditions: establishing accurate prevalence figures.